Pfizer Inc.

NYS : PFE
Pharmaceuticals
New York New York
2011 Revenue (US$ Millions)$67,425
2010 Revenue (US$ Millions)$67,809
Revenue Growth (%)-0.57%
Net Income (US$ Millions)$10,009
Common Shares Outstanding (Millions)$7,575
Earnings Per Share (US$)$1.27
Earnings Per Share Growth (%)24.51%
Price To Earnings Ratio17.05
Total Equity (US$ Millions)$82,190
Profit Growth (%)21.22
Profit Margin (%)14.84%
Return On Equity (%)11.40%
Long Term Debt (US$ Millions)$34,931
Debt To Equity Ratio (%)0.43%
Market Capitalization (US$ Millions)$163,923
Total Assets (US$ Millions)$188,002
Return on Assets (%)5.13
Current Assets (US$ Millions)$57,728
Inventories (US$ Millions)$7,769
Current Liabilities (US$ Millions)$28,069
Cost of Goods Sold (US$ Millions)$15,085
Asset Turnover0.36
Inventory Turnover1.87